(Q27001743)

Sharon G. Lynch

series ordinal

2

1 reference

Steven M. LeVine

series ordinal

3

1 reference

language of work or name

1 reference

30 January 2014

5 references

25 April 2019

30 June 2019

25 June 2019

2 October 2019

4 references

30 June 2019

25 June 2019

2 October 2019

6

1 reference

issue

1

1 reference

page(s)

e00136

1 reference

Creative Commons Attribution 3.0 Unported

copyright license

4 references

25 April 2019

30 June 2019

25 June 2019

on focus list of Wikimedia project

2 October 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Teriflunomide for multiple sclerosis

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Hypoxia-inducible factors in physiology and medicine

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

A non-heme iron-mediated chemical demethylation in DNA and RNA

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Glutamate receptors in neuroinflammatory demyelinating disease

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Perivascular iron deposition and other vascular damage in multiple sclerosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron and iron regulatory proteins in amoeboid microglial cells are linked to oligodendrocyte death in hypoxic neonatal rat periventricular white matter through production of proinflammatory cytokines and reactive oxygen/nitrogen species

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Increased cellular iron levels affect matrix metalloproteinase expression and phagocytosis in activated microglia

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Targeting chelatable iron as a therapeutic modality in Parkinson's disease

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Mitochondrial dysfunction and neurodegeneration in multiple sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Pathophysiology and treatment of neurodegeneration with brain iron accumulation in the pediatric population

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

A delicate balance: Iron metabolism and diseases of the brain.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron and neurodegeneration in the multiple sclerosis brain

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Co-enzyme Q10 and idebenone use in Friedreich's ataxia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron accumulation in multiple sclerosis: an early pathogenic event

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Treatment of classic pantothenate kinase-associated neurodegeneration with deferiprone and intrathecal baclofen

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Visualizing iron in multiple sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

DNA triplex structures in neurodegenerative disorder, Friedreich's ataxia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

The role of iron as a mediator of oxidative stress in Alzheimer disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

The conundrum of iron in multiple sclerosis--time for an individualised approach

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron chelation therapy in the management of transfusion-related cardiac iron overload.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Hypoxia inducible factor-1: its potential role in cerebral ischemia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Real-world use of iron chelators

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Pathogenic implications of iron accumulation in multiple sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

A pilot trial of deferiprone for neurodegeneration with brain iron accumulation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Induction of hypoxia inducible factor (HIF-1α) in rat kidneys by iron chelation with the hydroxypyridinone, CP94.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Prevalence of celiac disease in multiple sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Friedreich's ataxia: pathology, pathogenesis, and molecular genetics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Glutamate and ATP signalling in white matter pathology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Prophylactic neuroprotection against stroke: low-dose, prolonged treatment with deferoxamine or deferasirox establishes prolonged neuroprotection independent of HIF-1 function

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron-chelating therapy for transfusional iron overload

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Brain iron metabolism and its perturbation in neurological diseases.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Glucocorticoid protection of oligodendrocytes against excitotoxin involving hypoxia-inducible factor-1alpha in a cell-type-specific manner.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Inflammation in neurodegenerative diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Accumulation of oxidative DNA damage in brain mitochondria in mouse model of hereditary ferritinopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron redistribution as a therapeutic strategy for treating diseases of localized iron accumulation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Optimizing iron chelation strategies in beta-thalassaemia major.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Hemin toxicity: a preventable source of brain damage following hemorrhagic stroke.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Overview of iron chelation therapy with desferrioxamine and deferiprone.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Regulation of neuron mitochondrial biogenesis and relevance to brain health

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron homeostasis and its interaction with prolyl hydroxylases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Elevated metals compromise repair of oxidative DNA damage via the base excision repair pathway: implications of pathologic iron overload in the brain on integrity of neuronal DNA.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Is multiple sclerosis a mitochondrial disease?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Review of teriflunomide and its potential in the treatment of multiple sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Oligodendrocytes: Susceptibility to injury and involvement in neurologic disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Review: Mitochondria and disease progression in multiple sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Deferroxamine preconditioning promotes long-lasting retinal ischemic tolerance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Chelation of mitochondrial iron prevents seizure-induced mitochondrial dysfunction and neuronal injury

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Oligodendrocytes and myelination: the role of iron

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Preconditioning with cobalt chloride or desferrioxamine protects oligodendrocyte cell line (MO3.13) from tumor necrosis factor-alpha-mediated cell death

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Superficial siderosis: a case report and review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Action of chelators in iron-loaded cardiac cells: Accessibility to intracellular labile iron and functional consequences

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Therapeutic chelators for the twenty first century: new treatments for iron and copper mediated inflammatory and neurological disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

The macrophage scavenger receptor CD163.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Signalling hypoxia by HIF hydroxylases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Differential inhibition of inducible T cell cytokine secretion by potent iron chelators.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Redox-active metals, oxidative stress, and Alzheimer's disease pathology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

The nature of heme/iron-induced protein tyrosine nitration

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron toxicity and chelation therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron biology in immune function, muscle metabolism and neuronal functioning

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

The iron chelator L1 potentiates oxidative DNA damage in iron-loaded liver cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Use of desferrioxamine in the treatment of aceruloplasminemia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Immunohistochemical study of vascular injury in acute multiple sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron supplementation generates hydroxyl radical in vivo. An ESR spin-trapping investigation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Superficial siderosis of the central nervous system.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Role of iron and iron chelation in dopaminergic-induced neurodegeneration: implication for Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Inhibition of allergic encephalomyelitis by the iron chelating agent desferrioxamine: differential effect depending on type of sensitizing encephalitogen

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Perihematomal glutamate level is associated with the blood-brain barrier disruption in a rabbit model of intracerebral hemorrhage

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Copper/zinc chelation by clioquinol reduces spinal cord white matter damage and behavioral deficits in a murine MOG-induced multiple sclerosis model

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Effects of deferiprone on immune status and cytokine pattern in thalassaemia major

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Changes in uptake of vitamin B(12) and trace metals in brains of mice treated with clioquinol

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron deposits in multiple sclerosis and Alzheimer's disease brains

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Effect of deferoxamine on retinal lipid peroxidation in experimental uveitis.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Conjugated deferoxamine reduces blood-brain barrier disruption in experimental optic neuritis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Intramuscular desferrioxamine in patients with Alzheimer's disease

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron deprivation decreases ribonucleotide reductase activity and DNA synthesis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome

31 May 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Pre- and Postweaning Iron Deficiency Alters Myelination in Sprague-Dawley Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Selective iron chelation in Friedreich ataxia: biologic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Cellular management of iron in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Effects of chelators on iron uptake and release by the brain in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

The influence of deferiprone (L1) and deferoxamine on iron and essential element tissue level and parameters of oxidative status in dietary iron-loaded mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Inactivation of astrocytic glutamine synthetase by hydrogen peroxide requires iron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Intracellular oxidative activity and respiratory burst of leukocytes isolated from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Haptoglobin deficiency facilitates the development of autoimmune inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Investigation into the correlation between the structure of hydroxypyridinones and blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Intranasal delivery of deferoxamine reduces spatial memory loss in APP/PS1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Identification of the receptor scavenging hemopexin-heme complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Role of the NMDA receptor and iron on free radical production and brain damage following transient middle cerebral artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Comorbidities amongst patients with multiple sclerosis: a population-based controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Long-term improvement under deferiprone in a case of neurodegeneration with brain iron accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Apoferritin attenuates experimental allergic encephalomyelitis in SJL mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Pilot safety trial of deferiprone in 10 subjects with superficial siderosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Update on a patient with superficial siderosis on deferiprone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Lipophilic adamantyl- or deferasirox-based conjugates of desferrioxamine B have enhanced neuroprotective capacity: implications for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Desferrioxamine in chronic progressive multiple sclerosis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Design and synthesis of fluorinated iron chelators for metabolic study and brain uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Iron alters glutamate secretion by regulating cytosolic aconitase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Fenton chemistry and iron chelation under physiologically relevant conditions: Electrochemistry and kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia-ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Iron handling in hippocampal neurons: activity-dependent iron entry and mitochondria-mediated neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Iron chelation abrogates excessive formation of hydroxyl radicals and lipid peroxidation products in monocytes of patients with Eales' disease: direct evidence using electron spin resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-α and TGF-β1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Development of potential iron chelators for the treatment of Friedreich's ataxia: ligands that mobilize mitochondrial iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Acute-phase protein hemopexin is a negative regulator of Th17 response and experimental autoimmune encephalomyelitis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Glucosylated Deferiprone and Its Brain Uptake: Implications for Developing Glucosylated Hydroxypyridinone Analogues Intended to Cross the Blood−Brain Barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Iron efflux from oligodendrocytes is differentially regulated in gray and white matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Blockade of glutamate release from microglia attenuates experimental autoimmune encephalomyelitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Alternative treatment paradigm for thalassemia using iron chelators

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Iron status in children with recurrent episodes of tumefactive cerebral demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Oxidative damage to DNA in plaques of MS brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

[Clinical features of superficial siderosis].

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Iron is a potential key mediator of glutamate excitotoxicity in spinal cord motor neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Cytokine toxicity to oligodendrocyte precursors is mediated by iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Cellular iron status influences the functional relationship between microglia and oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FAN20130037

Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron-deficient mice fail to develop autoimmune encephalomyelitis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Differences in iron requirements by concanavalin A-treated and anti-CD3-treated murine splenic lymphocytes

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Iron deposits surrounding multiple sclerosis plaques.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906635

Nitrative and oxidative modifications of enolase are associated with iron in iron-overload rats and in vitro

28 November 2018

1 reference

12 December 2020

Hypoxia inducible factor-1α mediates iron uptake which induces inflammatory response in amoeboid microglial cells in developing periventricular white matter through MAP kinase pathway

1 reference

12 December 2020

Sequestration of iron by Lewy bodies in Parkinson's disease

1 reference

12 December 2020

A working protocol to be used as a guideline for trials in multiple sclerosis

1 reference

12 December 2020

The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethly-, 1,2 diethyl-, and 1-[ethan-1'ol]-2-methyl-3-hydroxypyridin-4-one in the rat

1 reference

12 December 2020

Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis

1 reference

12 December 2020

A further contribution to the knowledge of the Hallervorden-Spatz disease

1 reference

12 December 2020

Glutamate excitotoxicity in a model of multiple sclerosis

1 reference

12 December 2020

Iron requirements of human lymphocytes: relative contributions of intra- and extra-cellular iron

1 reference

12 December 2020

Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration

1 reference

12 December 2020

Erythropoiesis: Comparison of Cytotoxic Aldehyde Generation in Beta-Thalassemia Patients Chelated with Deferoxamine or Deferiprone (L1) Versus NO Chelation

1 reference

12 December 2020

MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation

1 reference

12 December 2020

Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation

1 reference

12 December 2020

A multiple course trial of desferrioxamine in chronic progressive multiple sclerosis

1 reference

12 December 2020

In vivo and in vitro iron deficiency reduces protein kinase C activity and translocation in murine splenic and purified T cells

1 reference

12 December 2020

T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study

1 reference

12 December 2020

Autoimmune encephalomyelitis ameliorated by AMPA antagonists

1 reference

12 December 2020

Serum elements and oxidative status in clinically isolated syndromes: Imbalance and predictivity

1 reference

12 December 2020

The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase

1 reference

12 December 2020

Identifiers

1 reference

1 reference

PubMed publication ID

24397846

1 reference